Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 14/20 | 0.59 |
| ▸ | PTGES | O14684 | 2/20 | 0.59 |
| ▸ | PNLIP | P16233 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.51 |
| ▸ | BCL9 | O00512 | 3/20 | 0.42 |
| ▸ | CTNNB1 | P35222 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | GSTO1 | P78417 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isorosmanol SCHEMBL14599481 | 0.82 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| Isorosmanol SCHEMBL12574307 | 0.82 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| Epiisorosmanol SCHEMBL29511557 | 0.82 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| Isorosmanol SCHEMBL13294492 | 0.82 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| Epirosmanol SCHEMBL3272202 | 0.78 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| Epirosmanol SCHEMBL29426648 | 0.78 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| Rosmanol SCHEMBL13062163 | 0.78 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| Rosmanol SCHEMBL28962181 | 0.78 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| Rosmanol SCHEMBL459610 | 0.78 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| SCHEMBL29385649 | 0.77 | FDPS (0.64) | FDPSPTGESPNLIPMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090022821-A1 | COMPOSITIONS FROM WAX MYRTLE FOR THE TREATMENT OF CANCER, CARDIOVASCULAR AND INFLAMMATORY DISEASES | DEV INDERJIT KUMAR | 2009-01-22 | — | — | US | claimed |
| US-20080187608-A1 | ENRICHED FRACTIONS FROM CLARY SAGE FOR THE TREATMENT OF CANCER, CARDIOVASCULAR AND INFLAMMATORY DISEASES | SAVIPU PHARMACEUTICALS (US) | 2008-08-07 | — | — | US | claimed |
| WO-2006072643-A1 | COMPOSITIONS COMPRISING NATURAL PRODUCTS FOR THE TREATMENT OF DIABETES | SUMINISTROS SOPREMA, S. L. (ES) | 2006-07-13 | — | — | WO | claimed |
| US-20250137015-A1 | YEAST PLATFORM FOR RENEWABLE INDUSTRIAL TERPENE PRODUCTION | Wang, Zhen (US) | 2025-05-01 | — | — | US | disclosed |
| CN-113262175-B | Skin care compositions and methods of use thereof | 尤尼根公司 | 2024-04-16 | — | — | CN | disclosed |
| US-20230027219-A1 | Skin Care Compositions and Methods of Use Thereof | UNIGEN, INC. (US) | 2023-01-26 | — | — | US | disclosed |
| US-11446225-B2 | Skin care compositions and methods of use thereof | UNIGEN, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| CN-113262175-A | Skin care compositions and methods of use thereof | 尤尼根公司 | 2021-08-17 | — | — | CN | disclosed |
| CN-105873564-B | Skin care compositions and methods of use thereof | 尤尼根公司 | 2021-01-19 | — | — | CN | disclosed |
| US-20200222304-A1 | Skin Care Compositions and Methods of Use Thereof | UNIGEN, INC. (US) | 2020-07-16 | — | — | US | disclosed |
| US-10603270-B2 | Skin care compositions and methods of use thereof | UNIGEN, INC. (US) | 2020-03-31 | — | — | US | disclosed |
| US-20160263013-A1 | Skin Care Compositions and Methods of Use Thereof | UNIGEN, INC. (US) | 2016-09-15 | — | — | US | disclosed |
| EP-3062767-A1 | SKIN CARE COMPOSITIONS AND METHODS OF USE THEREOF | Unigen, Inc. (US) | 2016-09-07 | — | — | EP | disclosed |
| WO-2015066352-A1 | SKIN CARE COMPOSITIONS AND METHODS OF USE THEREOF | UNIGEN, INC. (US) | 2015-05-07 | — | — | WO | disclosed |
| US-20090304827-A1 | Combinations of Ingredients Having Synergistic Anti-Inflammatory Effects | KIM DARRICK S H L | 2009-12-10 | — | — | US | disclosed |
| US-20090022821-A1 | COMPOSITIONS FROM WAX MYRTLE FOR THE TREATMENT OF CANCER, CARDIOVASCULAR AND INFLAMMATORY DISEASES | DEV INDERJIT KUMAR | 2009-01-22 | — | — | US | disclosed |
| US-20080187608-A1 | ENRICHED FRACTIONS FROM CLARY SAGE FOR THE TREATMENT OF CANCER, CARDIOVASCULAR AND INFLAMMATORY DISEASES | SAVIPU PHARMACEUTICALS (US) | 2008-08-07 | — | — | US | disclosed |
| WO-2006072643-A1 | COMPOSITIONS COMPRISING NATURAL PRODUCTS FOR THE TREATMENT OF DIABETES | SUMINISTROS SOPREMA, S. L. (ES) | 2006-07-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200222304-A1 | Skin Care Compositions and Methods of Use Thereof | CUTA, LGALS8, RBP1 | FDPS 4632/4885PTGES 4655/4885PNLIP 2019/4885 |
| US-20230027219-A1 | Skin Care Compositions and Methods of Use Thereof | CUTA, LGALS8, RBP1 | FDPS 4632/4885PTGES 4655/4885PNLIP 2019/4885 |
| US-20160263013-A1 | Skin Care Compositions and Methods of Use Thereof | CUTA, LGALS8, RBP1 | FDPS 4632/4885PTGES 4655/4885PNLIP 2019/4885 |
| US-11446225-B2 | Skin care compositions and methods of use thereof | CUTA, LGALS8, RBP1 | FDPS 4632/4885PTGES 4655/4885PNLIP 2019/4885 |
| US-10603270-B2 | Skin care compositions and methods of use thereof | CUTA, LGALS8, RBP1 | FDPS 4632/4885PTGES 4655/4885PNLIP 2019/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.